Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden
1996

Second Primary Cancers in Melanoma Patients

Sample size: 20354 publication Evidence: high

Author Information

Author(s): C Wassberg, M Thörn, J Yuen, U Ringborg, T Hakulinen

Primary Institution: University Hospital, Uppsala, Sweden; Karolinska Hospital, Stockholm, Sweden; Finnish Cancer Register, Helsinki, Finland.

Hypothesis

Patients with cutaneous malignant melanoma have an increased risk of developing second primary cancers.

Conclusion

Patients with malignant melanoma in Sweden have a 45% higher risk of developing second primary cancers compared to the general population.

Supporting Evidence

  • 1605 patients developed a second primary cancer compared to an expected 1109.5.
  • The highest risk was found in patients younger than 60 years.
  • The risk was significantly elevated even after 15 years of follow-up.
  • Men had a significantly higher SIR for second primary malignant melanoma at 10.0.

Takeaway

People who have skin cancer called melanoma are more likely to get another type of cancer later on, especially if they are younger than 60.

Methodology

The study analyzed data from the Swedish Cancer Register, tracking 20,354 melanoma patients from 1958 to 1988 to assess the incidence of second primary cancers.

Potential Biases

Increased surveillance may lead to detection bias, but the long-term elevated risk suggests this is not the main factor.

Limitations

The study may have underreported cases, and there could be misclassification of metastases as new primary cancers.

Participant Demographics

The cohort included 9,617 men and 10,737 women, with an average age at diagnosis of 56.7 years.

Statistical Information

P-Value

1.45

Confidence Interval

1.38-1.52

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication